Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
154.30
+0.51 (0.33%)
At close: Aug 1, 2025, 4:00 PM
157.02
+2.72 (1.76%)
After-hours: Aug 1, 2025, 6:02 PM EDT
Masimo Revenue
Masimo had revenue of $372.00M in the quarter ending March 29, 2025, with 9.54% growth. This brings the company's revenue in the last twelve months to $2.13B, up 16.68% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$2.13B
Revenue Growth
+16.68%
P/S Ratio
3.88
Revenue / Employee
$590,778
Employees
3,600
Market Cap
8.35B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MASI News
- 11 days ago - Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5 - Business Wire
- 25 days ago - Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation - Business Wire
- 7 weeks ago - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia - Business Wire
- 2 months ago - Masimo to Present in the Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - Masimo to Present in the BofA Securities 2025 Health Care Conference - Business Wire
- 3 months ago - Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln - Reuters
- 3 months ago - Masimo Reports First Quarter 2025 Results - Business Wire